Navigation Links
Final Vectibix Positive Pivotal Phase 3 Trial Results In Metastatic,Colorectal Cancer Patients Published

or performance, are easier to administer, or that are otherwise competitive with our products. In addition, while Amgen routinely obtains patents for Amgen's products and technology, the protection offered by Amgen's patents and patent applications may be challenged, invalidated or circumvented by Amgen's competitors and there can be no guarantee of Amgen's ability to obtain or maintain patent protection for Amgen's products or product candidates. Amgen cannot guarantee that it will be able to produce commercially successful products or maintain the commercial success of Amgen's existing products. Amgen or others could identify side effects or manufacturing problems with Amgen's products after they are on the market. Amgen's stock price may be affected by actual or perceived market opportunity, competitive position, and success or failure of Amgen's products or product candidates. Further, the discovery of significant problems with a product similar to one of Amgen's products that implicate an entire class of products could have a material adverse effect on sales of the affected products and on Amgen's business and results of operations.

EDITOR'S NOTE: An electronic version of this news release may be accessed via our Web site at www.amgen.com. Journalists and media representatives may sign up to receive all news releases electronically at time of announcement by filling out a short form in the Media section of the Web site.

Contact

Amgen
Christine Regan, 805-447-5476 (media)
Arvind Sood, 805-447-1060 (investors)


'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Human Genome Sciences Announces Positive Final Results Of Phase 2b Trial of Albuferon
2. Positive Final Data from HyCAMP Phase II Trial in Metastatic Colorectal
3. Intarcia Therapeutics Announces Presentation of Final Results From a Phase 2 Combination Study for the Treatment of Hepatitis C at the Digestive Disease Week Conference
4. Intarcia Therapeutics Announces Final Results From a Phase 2 Study of Injectable Omega Interferon plus Ribavirin for the Treatment of Hepatitis C Genotype-1
5. Cell Genesys Provides Final Median Survival Data From Second Phase 2 Trial of GVAX Immunotherapy for Prostate Cancer
6. Baxter Announces Final Phase I/II Data and Initiation of Phase III Clinical Trial for Candidate Pandemic H5N1 Influenza Vaccine
7. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Positive Aggrastat Results Featured in the Journal of the American College of Cardiology
9. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
10. Protox Announces Positive Clinical Data from Prostate Cancer Study
11. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
Post Your Comments:
(Date:3/3/2015)... 3, 2015  Cannabis Science, Inc. (OTCQB: CBIS), a ... today announced two important developments: It launched its toll-free ... launches, and CEO Raymond C. Dabney recently ... In the article, Dabney answers questions from ... company in an industry that is too new for ...
(Date:3/3/2015)... and Markets ( http://www.researchandmarkets.com/research/bsfm2s/cardiovascular ) has announced ... Drug Delivery - Technologies, Markets and Companies" to ... the cardiovascular system is different from delivery to other ... vascular system; it supplies blood and nutrients to all ... the vascular system for systemic effects or targeted to ...
(Date:3/3/2015)... NEW YORK , March 3, 2015 /PRNewswire/ ... a specialty pharmaceutical and medical device company focused ... of primary and metastatic liver cancers, announces that ... which completed enrollment in 2009, have been submitted ... The clinical study utilized Melphalan Hydrochloride for Injection ...
Breaking Medicine Technology:CBIS Momentum Continues: Company Opens Call Center In Preparation For New Product Releases & CEO Shares His 'Impressive And Insightful' Views With Columnist 2CBIS Momentum Continues: Company Opens Call Center In Preparation For New Product Releases & CEO Shares His 'Impressive And Insightful' Views With Columnist 3CBIS Momentum Continues: Company Opens Call Center In Preparation For New Product Releases & CEO Shares His 'Impressive And Insightful' Views With Columnist 4CBIS Momentum Continues: Company Opens Call Center In Preparation For New Product Releases & CEO Shares His 'Impressive And Insightful' Views With Columnist 5Global Cardiovascular Drug Delivery Technologies, Markets and Companies 2014-2024 2Global Cardiovascular Drug Delivery Technologies, Markets and Companies 2014-2024 3Delcath Announces Submission Of Phase 3 Trial Results For Publication In A Leading Peer-Reviewed Medical Journal 2Delcath Announces Submission Of Phase 3 Trial Results For Publication In A Leading Peer-Reviewed Medical Journal 3Delcath Announces Submission Of Phase 3 Trial Results For Publication In A Leading Peer-Reviewed Medical Journal 4
... 2011 Centre Partners Management LLC ("Centre Partners"), a leading ... and Los Angeles, today announced the completion of the sale ... Troy Limited (Nasdaq: HELE). Kaz is an international leader in ... valued at $260 million subject to certain closing working capital ...
... The MED Group, a Managed Health Care Associates, Inc. ...  The website was created to help answer questions for ... about competitive bidding and how patients can receive their ... Centers for Medicare and Medicaid Services (CMS) will be ...
Cached Medicine Technology:Centre Partners Announces Successful Realization of Investment in Kaz, Inc. 2Centre Partners Announces Successful Realization of Investment in Kaz, Inc. 3New Program for Medicare Beneficiaries Will Mean Major Changes Effective January 1, 2011 - Florida 2New Program for Medicare Beneficiaries Will Mean Major Changes Effective January 1, 2011 - Florida 3
(Date:3/3/2015)... Fla - (March 3, 2015) (PRWEB) March 03, 2015 ... Vacations, Inc. (FCV), an innovator in the travel industry ... in his trailblazing expansion plan. To fulfill his vision ... the addition of 400 fun, exciting and well-compensated positions ... headquarters and a news sales center planned for the ...
(Date:3/3/2015)... PLAINSBORO, N.J. (PRWEB) March 03, 2015 ... Simon Cancer Center have joined forces to share ... OncLive announced today. The collaboration is part of ... the new alliance, OncLive’s editorial and marketing teams ... a National Cancer Institute-designated cancer center, to highlight ...
(Date:3/3/2015)... The FSH Society , the ... little-known and incurable disease, facioscapulohumeral muscular dystrophy (FSHD), today ... The purpose of the campaign is to spread awareness ... common forms of muscular dystrophies. , To begin ... FSH Society will begin sharing impactful photographs of people ...
(Date:3/3/2015)... Presale tickets for Madonna will be ready ... begin on March 9, with Madonna tour tickets expected to ... by the talented artist is a significant one for fans, ... Visit Ticketability.com to browse the inventory of Madonna ... fans to enjoy, the 2015 tour is expected to attract ...
(Date:3/3/2015)... USA (PRWEB) March 03, 2015 ... rehabilitative prowess and prevention of probation programs aimed ... treatment undermines the excessive (tax) cost of incarcerating ... them in drug and alcohol addiction treatment. Governor ... crippling $25-$27.5 million from Illinois' drug and alcohol ...
Breaking Medicine News(10 mins):Health News:First Class Vacations, Inc. Expansion Plan Creates 400 Jobs In South Florida 2Health News:First Class Vacations, Inc. Expansion Plan Creates 400 Jobs In South Florida 3Health News:IU Simon Cancer Center Teams with OncLive® in Strategic Alliance Partnership 2Health News:IU Simon Cancer Center Teams with OncLive® in Strategic Alliance Partnership 3Health News:Share to be Aware: FSH Society Launches #CureFSHD Campaign 2Health News:Share to be Aware: FSH Society Launches #CureFSHD Campaign 3Health News:Presale Tickets for Madonna: Ticketability.com Announces Madonna Tour Tickets for Sale at Reduced Prices for the Rebel Heart Tour During Presales 2Health News:Gov. of Illinois, Bruce Rauner, Suggests Cutting 25 Million for Drug Rehabilitation, Harbor Village Comments 2
... to extract adult stem cells from adipose or fatty ... ,International scientists will announce findings from a significant ... adipose tissue could eventually be used to treat injured ... at the third annual International Fat Applied Technology Society ...
... syndrome (also referred to as meconium aspiration) occurs when ... fluid during labor and delivery. ,Meconium is ... pregnancy and is formed from ingested amniotic fluid and ... is highly irritating to the lung when the infant ...
... California, San Diego, had discovered that a single molecule ... etc., in the body. // ,By blocking ... find a way to stave off the most common ... major cause of childhood death and disability. The researchers’ ...
... discovered a kind of immune cells called macrophages are behind ... new lymph vessels help in healing of the eyes in ... discovery of this new role for the macrophage, published in ... innovative treatments for blinding eye disease, as well as for ...
... women in the inheritance of cancer as well. A genetic mutation ... significantly increases the danger of some cancers in men according to ... examined in the familial inheritance of breast cancer among women and ... in women who have a family history of breast and ovarian ...
... The U.S. research team led by Professor Claudio Soto from ... ‘prion’ proteins behind such diseases in the blood of experimental ... Mad Cow disease, raising hopes that people could be screened ... The researchers are now refining the method to find prions ...
Cached Medicine News:Health News:Adult Stem Cells From Fat Tissues For Healing 2Health News:Lymph Cell Growth In Eyes Related To Macrophages 2Health News:Genes responsible for cancer in women associated with increased cancer risk in men 2Health News:Blood Test To Detect Creutzfeldt-Jakob Disease/Mad Cow Disease 2
Cushing bayonet....
Straight, blunt tips....
Angled, pointed, with attached cable for Valleylab and other brands generators....
Autoclavable reusable pencil for Aaron 800 & 1200 - comes with generator or 1/box....
Medicine Products: